---
title: "diagnostic tests phosphatidylethanol test alcohol consumption"
year: 2023
month: 07
journal: "American Family Physician"
volume: "108"
issue: "07"
pages: ""
doi: ""
pmid: ""
source: "PDF Extraction"
pdf_available: true
original_pdf: "2023-07-diagnostic-tests-phosphatidylethanol-test-alcohol-consumption.pdf"
extracted_date: "2025-08-10"
keywords: []
evidence_level: ""
clinical_significance: ""
---

# diagnostic tests phosphatidylethanol test alcohol consumption

                                                    Diagnostic Tests
                                                  What Physicians Need to Know

         Phosphatidylethanol Test for Identifying
             Harmful Alcohol Consumption
                                   Elizabeth Williams, MD, and Jennifer G. Chang, MD, FAAFP
                                  Eglin Air Force Base Family Medicine Residency, Eglin Air Force Base, Florida


Phosphatidylethanol (PEth) is a
whole blood alcohol biomarker. It is           Test             Indication                           Population       Cost
detectable for up to four weeks after
                                               PEth blood       Identifies moderate to heavy         Age ≥ 18 years   $150 (may vary
consuming alcohol.1 A PEth level of            testing          alcohol consumption in the                            by region)11
20 ng per mL or higher is often used                            past four weeks*
as the threshold to identify moderate
                                               PEth = phosphatidylethanol.
to heavy alcohol consumption.2 The
                                               *—Moderate consumption is considered 2 to 4 drinks per day (28 to 56 g per day) several
U.S. Preventive Services Task Force            times per week or up to 60 g per day for men and 40 g per day for women. Heavy consump-
recommends using validated question-           tion is more than 4 drinks per day several times per week. 2
naires to screen for unhealthy alcohol
use but does not recommend PEth. 3
The American Psychiatric Association suggests testing for trauma incident.6 The AUROC curve was 0.791 (95% CI,
PEth or other alcohol biomarkers for ongoing monitoring 0.722 to 0.860;​n = 64) for alcohol misuse and 0.885 (95% CI,
or as part of the initial evaluation in patients with alcohol 0.830 to 0.939;​n = 33) for severe misuse.
use disorder.4                                                          Another meta-analysis identified 21 studies (n = 3,085)
                                                                     with positive AUDIT-C scores in women and men (3 or
Accuracy                                                             greater and 4 or greater, respectively) and found that 82%
In a small prospective randomized study (n = 44), healthy had detectable PEth levels (8 ng per mL or higher).7 Patients
adults were assigned to either three months of no alcohol with a body mass index of 30 kg per m2 or greater had lower
use or moderate consumption of red wine.5 Women in the odds of detectable PEth levels (odds ratio [OR] = 0.44;​95%
moderate consumption group were allowed 16 g of red CI, 0.28 to 0.69;​P < .001;​n = 427). Factors that led to a higher
wine per day, and men were allowed 33 g per day. In the probability of detectable PEth levels included normal or high
abstinence group, average PEth levels were 14.1 ng per mL hemoglobin (OR = 2.19;​95% CI, 1.34 to 3.59;​P < .002;​n =
at baseline and less than 3.5 ng per mL after three months 2,412) and advanced hepatic fibrosis (OR = 1.83;​95% CI, 1.24
(P = .001). PEth values in the moderate consumption group to 2.71;​ P < .002;​n = 183). PEth sensitivity was not affected
were 12.7 ng at baseline and 15.5 ng after three months when adjusted for age, ethnicity, HIV status, and method of
(P = .91). The area under the receiver operating characteris- blood collection (e.g., finger prick or venipuncture). Study
tic (AUROC) curve for PEth was 0.92 (95% CI, 0.82 to 1.0), findings are summarized in Table 1.5-7
demonstrating reliable accuracy for distinguishing between
abstention and moderate consumption of alcohol.                      Benefit
   Studies have shown good correlation between the Alcohol PEth can indicate recent alcohol consumption within the
Use Disorders Identification Test-Consumption (AUDIT-C) past month.6 Self-reporting tools, such as the AUDIT-C, may
and PEth. A large cross-sectional study of adult trauma be less accurate if impacted by recall bias;​PEth testing may
patients (n = 238) compared AUDIT-C scores with whole improve detection of harmful alcohol use in settings where
blood PEth levels that were drawn within six hours of the patients underreport their alcohol consumption.6,8

                                                                                 Harms
  This series is coordinated by Natasha Pyzocha, DO, contrib-
  uting editor.                                                                  PEth levels cannot determine the specific amount or pattern
  A collection of Diagnostic Tests published in AFP is available                 of alcohol consumed.9 PEth testing is best used to detect
  at https://​w ww.aafp.org/afp/diagnostic.                                      moderate or heavy alcohol use over a four-week period.1,6,7
  Author disclosure:​No relevant financial relationships.                        Although the correlation between AUDIT-C scores and
                                                                                 PEth is moderately strong, PEth cannot distinguish

 Downloaded
July         from the108,
     2023 ◆ Volume    American Family
                          Number  1 Physician website at www.aafp.org/afp.        © 2023 American Academy of Family
                                                                           Copyright
                                                            www.aafp.org/afp                                    American    Family
                                                                                                                     Physicians.      Physician
                                                                                                                                 For the           95
                                                                                                                                         private, non-
commercial use of one individual user of the website. All other rights reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.
                                                                DIAGNOSTIC TESTS
    TABLE 1

    Summary of Studies Assessing PEth Levels in the Identification of Alcohol Misuse
    Study                      AUROC curve                        Cutoff                              Sensitivity     Specificity     LR+      LR–

    44 healthy adults5        0.92 (95% CI, 0.82 to 1.0)          4.2 ng per mL or below:​            100%            78%             4.5      0.013
                                                                  abstinence
                                                                  28 ng per mL or greater:​           28%             100%            28       0.72
                                                                  moderate consumption

    238 adult trauma          0.791 (95% CI, 0.722 to             18.3 ng per mL or greater:​         —               —               —        —
    patients6                 0.860) for alcohol misuse           alcohol misuse
                              0.885 (95% CI, 0.830 to             23.9 ng per mL or greater:​         —               —               —        —
                              0.939) for severe misuse            severe misuse

    3,085 patients in         —                                   Greater than 8 ng per mL            82%             —               —        —
    21 studies7                                                   (limit of quantification for
                                                                  any use of alcohol)

    AUROC = area under the receiver operating characteristic;​LR+ = positive likelihood ratio;​LR– = negative likelihood ratio;​PEth =
    phosphatidyl­ethanol.
    Information from references 5-7.



abstinence from light drinking.9 It should not be used to                         2. Ulwelling W, Smith K. The PEth blood test in the security environment:​
                                                                                     what it is;​why it is important;​and interpretative guidelines. J Forensic
confirm abstinence.                                                                  Sci. 2018;​63(6):​1634-1640.
                                                                                  3. Curry SJ, Krist AH, Owens DK, et al. Screening and behavioral counsel-
Cost                                                                                 ing interventions to reduce unhealthy alcohol use in adolescents and
                                                                                     adults:​US Preventive Services Task Force recommendation statement.
PEth is measured through whole blood sampling via veni-                              JAMA. 2018;​320(18):​1899-1909.
puncture or capillary dried blood spot under Current Pro-                         4. Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric
cedural Terminology (CPT) code 80321.10 PEth testing costs                           Association practice guideline for the pharmacological treatment of
                                                                                     patients with alcohol use disorder. Am J Psychiatry. 2018;​175(1):​86-90.
approximately $150.11 An Advance Beneficiary Notice of                            5. Kechagias S, Dernroth DN, Blomgren A, et al. Phosphatidylethanol
Noncoverage may be required to cover the cost of PEth tests                          compared with other blood tests as a biomarker of moderate alcohol
for patients with Medicare.12                                                        consumption in healthy volunteers:​a prospective randomized study.
                                                                                     Alcohol Alcohol. 2015;​50(4):​399-406.
                                                                                  6. Gerbase FE, Tegner M, Krutzmann ME, et al. Blood phosphatidyl eth-
Bottom Line                                                                          anol levels as a tool to detect alcohol misuse in trauma patients. Clin
PEth testing should be used only when clinical uncertainty                           Toxicol (Phila). 2021;​59(5):​418-425.
remains after employing other standard assessments to                             7. Hahn JA, Murnane PM, Vittinghoff E, et al. Factors associated with phos-
                                                                                     phatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use:​
detect harmful alcohol consumption over the previous four                            an individual patient data meta-analysis. Alcohol Clin Exp Res. 2021;​
weeks. Although it is sensitive and specific, the sensitivity                        45(6):​1 166-1187.
may be increased in patients with normal or elevated hemo-                        8. Eyawo O, McGinnis KA, Justice AC, et al.;​VACS Project team. Alco-
                                                                                     hol and mortality:​combining self-reported (AUDIT-C) and biomarker
globin levels and advanced hepatic fibrosis and decreased in                         detected (PEth) alcohol measures among HIV infected and uninfected.
patients with a body mass index of 30 kg per m2 or greater.                          J Acquir Immune Defic Syndr. 2018;​7 7(2):​1 35-143.
There are no consensus guidelines for use of PEth testing in                      9. Schröck A, Wurst FM, Thon N, et al. Assessing phosphatidylethanol
                                                                                     (PEth) levels reflecting different drinking habits in comparison to the
clinical settings.13                                                                 alcohol use disorders identification test - C (AUDIT-C). Drug Alcohol
The views and opinions expressed herein are solely those of the                      Depend. 2017;​178:​80-86.
                                                                                 10. Labcorp. Phosphatidylethanol (PEth). Accessed September 4, 2022.
authors and do not necessarily represent the position of the U.S.
                                                                                     https://www.labcorp.com/tests/791584/phosphatidylethanol-peth
Air Force, the U.S. Department of Defense, or the U.S. govern-
                                                                                 11. RequestATest. Phosphatidylethanol (PEth) alcohol test. Accessed Jan-
ment at large.                                                                       uary 17, 2023. https://​requestatest.com/phosphatidylethanol-peth-
Address correspondence to Jennifer G. Chang, MD, FAAFP, at                           alcohol-test
jennifer.g.chang.mil@​health.mil. Reprints are not available from                12. Quest Diagnostics. Phosphatidylethanol, blood. Accessed September 4,
                                                                                     2022. https://​testdirectory.questdiagnostics.com/test/test-detail/37850/
the authors.
                                                                                     phosphatidylethanol-blood?cc=TMP
                                                                                 13. Luginbühl M, Van Uytfanghe K, Stöth F, et al. Current evolutions, appli-
References                                                                           cations, and challenges of phosphatidylethanol analysis for clinical
 1. Isaksson A, Walther L, Hansson T, et al. Phosphatidylethanol in blood            and forensic purposes. WIREs:​Forensic Sci. 2022(4):​e1456. Accessed
    (B-PEth):​a marker for alcohol use and abuse. Drug Test Anal. 2011;​3(4):​       May 31, 2022. https://​wires.onlinelibrary.wiley.com/doi/epdf/10.1002/
    195-200.                                                                         wfs2.1456 ■




96 American Family Physician                                     www.aafp.org/afp                                     Volume 108, Number 1 ◆ July 2023
